Traditional Indian systems of medicine

Annals of the Academy of Medicine Singapore

Volumn 29, Issue 1, 2000, Pages 37-41

  Lodha, R ^b   Bagga, A ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b NONE

Author keywords

Ayurveda; Complententary medicine; Diabetes meilitus; Mental retardation; Rheumatoid arthritis

Indexed keywords

AYURVEDIC DRUG; SETON; UNCLASSIFIED DRUG;

ALTERNATIVE MEDICINE; ARTICLE; ASTHMA; DIABETES MELLITUS; DRUG INDICATION; DRUG USE; HUMAN; INDIAN; MEDICAL INFORMATION; MENTAL DEFICIENCY; RHEUMATOID ARTHRITIS; TRADITIONAL MEDICINE;

EID: 0034117911     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Satyavati G V. Some traditional medical systems and practices of global importance. Indian J Med Res 1982; 76(Suppl): 1-26.
2. Malone M H. The pharmacological evaluation of natural products-general and specific approaches to screening ethnopharmaceuticals. J Ethnopharmacol 1983; 8:127-47.
3. Subbarayappa B V. Siddha medicine: an overview. Lancet 1997; ii:1841-4.
4. Gupta S S. Development of antihistamine and antiallergic activity after prolonged administration of a plant saponin from Clerodendron serratum. J Pharm Pharmacol 1968; 20:801-2.
5. Gupta S S. Indigenous drugs in experimental bronchial asthma. Aspect Aller Appl Immunol 1971; 5:31-42.
6. Tripathi R M, Das P K. Studies on anti-asthmatic and anti-anaphylactic activity of Albizzia lebbek. Indian J Pharmacol 1977; 9:189-94.
7. Govindan S, Viswanathan S, Vijayasekaran V, Alagappan R. A pilot study on the clinical efficacy of Solanum xanthocarpum and Solanum trilobatum in bronchial asthma. J Ethnopharmacol 1999; 66:205-10.
8. Iyengar M A, Jambaiah K M, Kamath M S, Rao G M. Studies on an anti-asthmatic kada - a proprietary herbal combination. Part 1: clinical study. Indian Drugs 1994; 31:183-6.
9. Iyengar M A, Jambaiah K M, Kamath M S, Rao G M. Studies on an anti-asthmatic kada - a proprietary herbal combination. Part II: pharmacological studies. Indian Drugs 1994; 31:187-91.
10. Deodhar S D, Sethi R, Srimal R C. Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). Indian J Med Res 1980; 71:632-4.
11. Kulkarni R R, Patki P S, Jog V P, Patwardhan B. Efficiency of an Ayurvedic formulation in rheumatoid arthritis - a double-blind, placebo controlled crossover study. Indian J Pharmacol 1992; 24:98-101.
12. Khanna N M. Turmeric - Nature's precious gift. Curr Science 1999; 76:1351-6.
13. Gupta S S, Shrivastava M C. Anti-inflammatory studies of Tinospora cordifolia (Gudichi). Indian J Pharmacol 1966; 6:12-5.
14. Banerjee S, Bandyopadhyay S K, Mukerjee P K, Mukerjee A, Sikdar S. Further studies on the anti-inflammatory activity of Ricinus communis in albino rats. Indian J Pharmacol 1991; 23:149-52.
15. Satyavati G V, Prasad D N, Das P K, Singh H D. Anti-inflammatory activity of Semecarpus anacardium Linn: a preliminary study. Indian J Physiol Pharmacol 1969; 13:37-45.
16. Gupta A, Saifi A Q, Modi N T, Rao S S, Mishra N. Anti-inflammatory activity of active principles of Lawsonia inermis leaves. Indian J Pharmacol 1990; 22:27-30.
17. Singh S, Majumdar D K, Rehan H M S. Evaluation of anti-inflammatory potential of fixed oil of Ocimum sanctum (holybasil) and its possible mechanism of action. J Ethnopharmacol 1996: 54:19-26.
18. Bhatt A D, Bhatt N S. Indigenous drugs and liver disease. Indian J Gastroenterol 1996; 15:63-7.
19. De S, Ravishankar B, Bhavsar G C. Plants with hepatoprotective activity - a review. Indian Drugs 1993; 30:355-63.
20. Vaidya A B, Antarkar D S, Athavale A V, Ramesh V, Baxi A J. Doshi J C. Treatment of acute viral hepatitis with Picrorrhiza kurroa. Annual Conference of the Association of Physicians of India; 1981 Jan 19-22; Nagpur, India.
21. Das D G. A double-blind clinical trial of Kamalahar, an indigenous compound preparation, in acute viral hepatitis. Indian J Gastroenterol 1993; 12:126-8.
22. Antarkar D S, Vaidya A B, Doshi J C, Athavale A V, Vinchoo K S, Natekar M R, et al. A double-blind clinical trial of Arogya-wardhini, an ayurvedic drug, in acute viral hepatitis. Indian J Med Res 1980; 72:588-93.
23. Thyagarajan S P, Subramanian S, Thirunalasundari T, Venkateswaran P S, Blumberg B S. Effects of Phyllanthus amarus on chronic carriers of hepatitis B virus. Lancet 1988; ii:764-6.
24. Leelarasmee A, Trakulsamboon S, Maunwongyathi P, Somanabandhu A, Pidetcha P, Matrakool B, et al. Failure of Phyllanthus amarus to eradicate hepatitis B surface antigen from symptomless carriers. Lancet 1990; i:1600-1.
25. Berk L, de Man R A, Schalm S W, Labadie R P, Heijtink R A. Beneficial effects of Phyllanthus amarus for chronic hepatitis B, not confirmed. J Hepatol 1991; 12:405-6.
26. Doshi J C, Vaidya A B, Antarkar D S, Deolalikar R, Antani D H. A two stage clinical trial of Phyllanthus amarus in hepatitis B carriers: failure to eradicate the surface antigen. Indian J Gastroenterol 1994; 13:7-8.
27. Dwivedi S, Agarwal M P. Antianginal and cardioprotective effects of Terminalia arjuna, an indigenous drug, in coronary artery disease. J Assoc Physicians India 1994; 42:287-9.
28. Bharani A, Ganguly A, Bhargava K D. Salutary effect of Terminalia arjuna in patients with refractory heart failure. Int J Cardiol 1995; 49:191-9.
29. Dwivedi S, Jauhari R. Beneficial effects of Terminalia arjuna in coronary artery disease. Indian Heart J 1997; 49:507-10.
30. Satyavati G V. Gumguggul (Commiphoramukul) - the success story of an ancient insight leading to a modern discovery. Indian J Med Res 1988;87:327-35.
31. Malhotra S C, Ahuja M M, Sundaram K R. Long term clinical studies on hypolipidaemic effect of Commiphora mukul (Guggulu) and clofibrate. Indian J Med Res 1977; 65:390-5.
32. Sharma H M, Hanna A N, Kauffman E M, Newman H A. Inhibition of human low-density lipoprotein oxidation in vitro by Maharishi Ayur-Veda herbal mixtures. Pharmacol Biochem Behav 1992; 43:1175-82.
33. Sundaram V, Hanna A N, Lubow G P, Koneru L, Falko J M, Sharma H M. Inhibition of low-density lipoprotein oxidation by oral herbal mixtures Maharishi Amrit Kalash-4 and Maharishi Amrit Kalash-5 in hyperlipidemic patients. Am J Med Sci 1997; 314:303-10.
34. Dwivedi S, Amrita. Medicinal plants with antiplatelet activity. Indian Drugs 1993; 30:539-48.
35. Aiman R. Recent research in indigenous anti-diabetic medicinal plants-an overall assessment. Indian J Physiol Pharmacol 1970; 14:65-76.
36. Ivorra M D, Paya M, Villar A. A review of natural products and plants as potential antidiabetic drugs. J Ethnopharmacol 1989; 27:243-5.
37. Indian Council of Medical Research Collaborating Centers. Flexible-dose open trial of Vijayasar in cases of newly diagnosed non-insulin-dependent diabetes mellitus. Indian J Med Res 1998; 108:24-9.
38. Kapur S K. Review on ethno-medico plants for skin afflictions. Indian Drugs 1991; 28:210-23.
39. Paranjpe P, Kulkarni P H. Comparative efficacy of 4 Ayurvedic formulations in the treatment of acne: a double-blind randomized placebo-controlled clinical evaluation. J Ethnopharmacol 1995; 49:127-32.
40. Damodaran S, Venkataraman S. A study on the therapeutic efficacy of Cassia alata leaf extract against Pityriasis versicolor. J Ethnopharmacol 1994; 42:19-23.
41. Mohite J D, Gawai R S. Rohondia D S, Bapat R D. Ksharsootra (medicated seton) treatment for fistula-in-ano. Indian J Gastroenterol 1997; 16:96-7.
42. Deshpande P J, Sharma K R. Treatment of fistula-in-ano by a new technique. Review and follow-up of 200 cases. Am J Proctol 1973; 24:49-60.
43. Shukla N K, Narang R, Nair N G K, Radhakrishna S, Satyavati G V. Multicentric, randomized, controlled, clinical trial of ksharsootra in the management of fistula-in-ano. Indian J Med Res 1991; 94:177-85.
44. Bagchi G D, Singh A, Khanuja S P, Singh S C, Kumar S. Wide spectrum antibacterial and antifungal activities in the seeds of some coprophilous plants of north Indian plains. J Ethnopharmacol 1999; 64:69-77.
45. Agrawal A K, Tripathi D M, Sahai R, Gupta N, Saxena K C. Management of giardiasis by a herbal drug "Pippali Rasayana": a clinical study. J Ethnopharmacol 1997; 56:233-6.
46. Dandiya P C, Chopra Y M. CNS acting drugs from plants indigenous to India. Indian J Pharmacol 1970; 2:67-90.
47. Dhawan B N. Centrally acting agents from Indian plants. In: Kaslow S H, Murthy R S, Coelho G V, editors. Decade of the Brain: India/ USA research in Mental Health and Neurosciences. Rockville: National Institute of Mental Health, 1995:197-202.
48. Vaidya A B. The status and scope of Indian medicinal plants acting on central nervous system. Indian J Pharmacol 1997; 29(Suppl):340S-343S.
49. Vaidya A B, Rajagopalan T G, Mankodi N A, Antarkar D S, Tathed P S, Purohit A V, et al. Treatment of Parkinson's disease with the cowhage plant - Mucuna pruriens Bak. Neurology (India) 1978; 28:171-5.
50. Agarwal A, Pandey M N, Dubey G P. Management of mental deficiency by an indigenous drug Brahmi (Bacopa monnieri). Pharmacopsychoccologia 1993; 6:1-5.
51. Gupta B S, Gehlot S, Dubey G P. Effect of simultaneous oral administration of Brahmi (Bacopa monnieri) and Vacha (Acorus calamus) on cognitive functions. Pharmacopsychoccologia 1994; 7:245-8.
52. Smit H F, Woerdenbag H J, Singh R H, Meulenbeld G J, Labadie R P, Zwaving J H. Ayurvedic herbal drugs with possible cytostatic activity. J Ethnopharmacol 1995; 47:75-84.